The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
| Location: |
Federal |
| Posted: |
Aug 28, 2026 |
| Due: |
Sep 4, 2026 |
| Agency: |
HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: |
Federal |
| Category: |
|
| Solicitation No: |
75N98026Q01067 |
| Publication URL: |
To access bid details, please log in. |
Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
Active
Contract Opportunity
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NHLBI
General Information
-
Contract Opportunity Type: Special Notice (Original)
-
Original Published Date: Aug 28, 2026 02:50 pm EDT
-
Original Response Date: Sep 04, 2026 10:00 am EDT
-
Inactive Policy: 15 days after response date
-
Original Inactive Date:
Sep 19, 2026
-
Initiative:
Classification
-
Original Set Aside:
-
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
-
NAICS Code:
-
621511 - Medical Laboratories
-
Place of Performance:
Description
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Attachments/Links
Contact Information
Contracting Office Address
-
6701 ROCKLEDGE DRIVE ROOM 6100
-
BETHESDA , MD 20892
-
USA
Secondary Point of Contact
History
-
Aug 28, 2026 02:50 pm EDTSpecial Notice (Original)
Daily notification on new contract opportunities
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
ONE WEEK FREE TRIAL
* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.